Genomic Vision Société Anonyme (0QT4.L)
| Previous close | 0.1771 |
| Open | 0.1432 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.1432 - 0.1432 |
| 52-week range | 0.1432 - 0.1432 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | -0.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Genomic Vision Announces the Approval by Its Shareholders’ Meeting of All the Resolutions Supported by the Executive Board
BAGNEUX, France, May 23, 2022--Regulatory News: Genomic Vision (FR0011799907 – GV – the "Company"), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, informs its shareholders that the Extraordinary Shareholders’ Meeting held today was able to validly deliberate.
- Business Wire
Genomic Vision Announces the Signing of an Addendum to the Contract Signed with Winance on April 11, 2022 for the Purpose of Implementing a New Financing Line, Subject to the Prior Approval of the Company’s Shareholders
BAGNEUX, France, May 20, 2022--Regulatory News: Genomic Vision (FR0011799907 – GV – the "Company"), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced the signing of an addendum to the contract signed with Winance on April 11, 2022 for the purpose of implementing a new financing line providing for the provision, subject to the prior approval of the Shareholders’ Meeting of May 23, 2022 and the conditions for dr
- Business Wire
Genomic Vision: Financial Information for the First Quarter of 2022
BAGNEUX, France, May 05, 2022--Regulatory News: Genomic Vision (FR0011799907 – GV – the "Company") (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today reported its revenue for the first quarter and its cash position at March 31, 2022.
